Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04555954
Other study ID # 2020/8/318
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 11, 2020
Est. completion date August 20, 2020

Study information

Verified date September 2020
Source Pamukkale University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Abstract Background: With Covid-19 pandemic, online education, remote and flexible working were introduced. Thus the process of stay-at-home began.

Purpose: The aim of the study is to determine level of physical activity of healthy adults in the pandemic process.

Methods: This is a descriptive survey study which was applied via internet. The physical activity level was evaluated with International Physical Activity Questionnaire Short Form. Healthy adults aged 18-65 years who live in Turkey were included in the study.


Description:

Study design This study, which was planned as a prospective, descriptive, cross-sectional survey study, had online-based questions. The participants answered the questions via the internet between April-July 2020. Ethical approval of the study was obtained from the Non-Interventional Clinical Research Ethics Committee of Afyonkarahisar Health Science University (Date/issue:2020/318) and the study follows the principles of the Declaration of Helsinki. All individuals were informed through written online documents and they were permitted to answer the questions after the informed consent approval button was clicked.

Participants Communication with the participants of the study was conducted via online survey software (Google Forms) and social media communication application (WhatsApp). The inclusion criteria for the participants were as follows; to be between the age of 18-65, healthy (physically, psychologically and cognitively) and to live in Turkey. Individuals with pregnancy, with a history of any surgery in the last 6 months, and with the presence of any acute or chronic diseases (infection-related, neurological, rheumatological, cardiovascular, orthopedic… etc.) were excluded from the study.

Outcome measures The demographic data of the participants and the International Physical Activity Questionnaires-Short Form (IPAQ-SF) were recorded using the internet. Participants needed approximately 10 minutes to answer the questions.

International Physical Activity Questionnaires-Short Form (IPAQ-SF): In our study, we used IPAQ-SF which was developed for international screening studies with the support of the WHO. The validity and reliability of the Turkish version of the questionnaire were performed by Sağlam et al. (2010). The short form of the questionnaire (7 questions) provides information about walking, moderate and vigorous activities and time spent sitting. Total score calculation of the short form included the sum of frequency (days) and duration (minutes) of walking, moderate and vigorous activities. The energy required for the activities was calculated with the Metabolic Equivalent of Task (MET)-minute score. The sitting score (sedentary behavior level) was calculated separately. A score as "MET-minute / week" was obtained by multiplying the minute, day and MET value (multiples of resting oxygen consumption). Walking time (minutes) was multiplied by 3.3 MET for the calculation of the walking score. During the calculation, 4 MET values for a moderate activities, and 8 MET values for vigorous activities were used. Following the calculation, a MET score under 600 was regarded as physically inactive; a score between 600 and 3000 was regarded as minimally active and a score of over 3000 was regarded as sufficiently active or Health-Enhancing Physical Activity.


Recruitment information / eligibility

Status Completed
Enrollment 205
Est. completion date August 20, 2020
Est. primary completion date July 31, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

The inclusion criteria for the participants were as follows;

- to be between the age of 18-65,

- healthy (physically, psychologically and cognitively)

- to live in Turkey.

Exclusion Criteria:

- The exclusion criteria for the participants were as follows;

- individuals with pregnancy,

- to have a history of any surgery in the last 6 months,

- with the presence of any acute or chronic diseases (infection-related, neurological, rheumatological, cardiovascular, orthopedic… etc.)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
surveys and questionnaires
The study practised the physical activity levels of healthy adults aged 18-65 years in Turkey during the novel type of coronavirus pandemic by the International Physical Activity Questionnaires-Short Form (IPAQ-SF). Communication with the participants of the study was conducted via online survey software (Google Forms) and social media communication application (WhatsApp).

Locations

Country Name City State
Turkey Afyonkarahisar Health Science University Afyonkarahisar

Sponsors (1)

Lead Sponsor Collaborator
Pamukkale University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary physical activity level MET-minute score: International Physical Activity Questionnaires-Short Form (IPAQ-SF): In our study, we used IPAQ-SF which was developed for international screening studies with the support of the WHO. The validity and reliability of the Turkish version of the questionnaire were performed by Saglam et al. (2010). The short form of the questionnaire (7 questions) provides information about walking, moderate and vigorous activities and time spent sitting. Total score calculation of the short form included the sum of frequency (days) and duration (minutes) of walking, moderate and vigorous activities. The energy required for the activities was calculated with the Metabolic Equivalent of Task (MET)-minute score. 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1